We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nanoparticle Targeting May Revolutionize Cardiac Photoablation Therapy

By LabMedica International staff writers
Posted on 09 Nov 2015
Print article
Image: Micrographs show a cardiac myocyte cell (top) and an attached fibroblast cell (bottom) in a rat heart, after the injection of the newly developed nanoparticle. In the second frame, red light has been applied. The red coloring indicates that the myocyte, which causes cardiac arrhythmia, has been killed, while the fibroblast remains unharmed (Photo courtesy of the University of Michigan).
Image: Micrographs show a cardiac myocyte cell (top) and an attached fibroblast cell (bottom) in a rat heart, after the injection of the newly developed nanoparticle. In the second frame, red light has been applied. The red coloring indicates that the myocyte, which causes cardiac arrhythmia, has been killed, while the fibroblast remains unharmed (Photo courtesy of the University of Michigan).
A light-based therapeutic approach to correct cardiac arrhythmia has been improved by the development of a nanotechnique that allows precise delivery of photosensitive molecules to malfunctioning cardiomyocytes while avoiding normal cells.

Abnormal heartbeats, called arrhythmias, can be stopped by photoablation (light-induced killing), but the use of light energy to terminate malfunctioning cardiomyocytes runs the risk of damaging the other dozen or so cell types in the heart.

To increase the precision of the photoablation procedure investigators at the University of Michigan (Ann Arbor, USA) engineered a type of nanoparticle containing a cardiac-targeting peptide (CTP) and a photosensitizer, chlorin e6 (Ce6), for specific delivery to myocytes. After uptake by myoctes, low energy laser light introduced through a catheter destroyed only the cells that had absorbed the nanoparticles, leaving the other heart cells unharmed.

The investigators reported in the October 28, 2015, online edition of the journal Science Translational Medicine that they confirmed the specificity of the method in vitro using adult rat heart cell and human stem cell–derived cardiomyocyte and fibroblast co-cultures. In vivo, the CTP-Ce6 nanoparticles were injected intravenously into rats and, upon laser illumination of the heart, induced localized, myocyte-specific ablation with 85% efficiency, restoring sinus rhythm without collateral damage to other cell types in the heart, such as fibroblasts. In both sheep and rat hearts ex vivo, upon perfusion of CTP-Ce6 particles, laser illumination led to the formation of a complete electrical block at the ablated region and restored the physiological rhythm of the heart.

"In our cancer work, we used nanoparticles that were about 120 nanometers in size," said contributing author Dr. Raoul Kopelman, professor of chemistry, physics, and applied physics at the University of Michigan. "To work inside the heart, we needed to develop a particle that did the same job but was only six nanometers in size. The great thing about this treatment is that it is precise down to the level of individual cells. Drugs spread all over the body and high-power lasers char the tissue in the heart. This treatment is much easier and much safer."

Related Links:

University of Michigan


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.